Dr. Olga Kubassova to Deliver Keynote Lecture at 1st International Summit of Inflammatory Bowel Disease Monitoring
LONDON, UK and CHICAGO, IL – Prof. David Rubin and the University of Chicago are inviting Dr. Olga Kubassova to present a keynote lecture at the 1st International Summit of Inflammatory Bowel Disease Monitoring: The Next Frontier of Prediction & Prevention, taking place in Chicago, IL, from March 14-15, 2025.
Dr. Kubassova’s keynote lecture, titled “Is the Pathologist Still Necessary?: AI-Assisted Pathology,” will explore the transformative role of artificial intelligence in pathology and its implications for disease monitoring and management.
This presentation will highlight how AI tools are reshaping traditional workflows, enhancing diagnostic precision, and fostering collaboration between technology and medical professionals. Following the lecture, attendees will have the opportunity to discuss and debate this critical topic with Dr. Kubassova.
The summit is designed for physicians, scientists, engineers, innovators, and healthcare professionals dedicated to advancing IBD management.
Key learning objectives include:
- Addressing limitations in current IBD monitoring modalities
- Exploring advancements in home-based and point-of-care monitoring technologies
- Applying digital health tools and endoscopic innovations in clinical practice
- Assessing remote monitoring capabilities for IBD management
- Analyzing innovative techniques for clinical trials
Dr. Kubassova’s expertise in AI-driven solutions for healthcare positions her as a leading voice in this emerging field. Her participation underscores the summit’s commitment to fostering dialogue on cutting-edge approaches to IBD prediction and prevention.
About Image Analysis Group (IAG)
IAG is a leading imaging Clinical Research Organization (iCRO) that combines medical and operational expertise with cutting-edge proprietary technologies to more efficiently advance drug development and deliver the potential for companion diagnostic tools. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to IV imaging trials across multiple indications. With a pioneering, proven innovation strategy, we enhance novel therapeutic assets’ value and market potential, as demonstrated through successful pharmaceutical partnerships.
Reach out: imaging.experts@ia-grp.com
Contact: Brittany Kearns
Phone: 571-271-7211
Email: brittany@crossroadsb2b.com